Literature DB >> 11556835

Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method.

S Casadei1, L Cortesi, V Pensotti, P Radice, M Pierotti, D Amadori, D Calistri.   

Abstract

We describe the Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method set up for a sensitive and preliminary rapid screening of BRCA1 mutations. We analysed exons 11 and 16, which are known to cover slightly more than 70% of the whole coding region of the gene, subdivided into 4 amplicons and labelled with different fluorescent dUTPs. MD-CFLP was first utilised on a panel of 30 DNA samples in which the presence of single-base substitutions or small deletions/insertions had been previously identified by direct sequencing as gold standard, in order to define the optimal conditions in terms of PCR amplification and temperature of digestion. In a second step, we blindly analysed 21 DNA samples by MD-CFLP to verify its reliability. The sensitivity and specificity of MD-CFLP were both 100% in the first study, and 80% and 94%, respectively, in the blind sample assay. Our results demonstrate the capability of the MD-CFLP method to detect DNA sequence alterations in fragments of more than 1 kb. We conclude that CFLP is a powerful tool in mutational analysis, offering reliable results in a shorter time and at a lower cost than conventional methods, and its potential can be enhanced when internal fluorescent labelling and laser detection are used. Copyright 2001 Cancer Research Campaign http://www.bjcancer.com.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11556835      PMCID: PMC2375072          DOI: 10.1054/bjoc.2001.1988

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  17 in total

1.  Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

Authors:  O M Serova; S Mazoyer; N Puget; V Dubois; P Tonin; Y Y Shugart; D Goldgar; S A Narod; H T Lynch; G M Lenoir
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

2.  The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.

Authors:  P Hartge; J P Struewing; S Wacholder; L C Brody; M A Tucker
Journal:  Am J Hum Genet       Date:  1999-04       Impact factor: 11.025

3.  Identification of the breast cancer susceptibility gene BRCA2.

Authors:  R Wooster; G Bignell; J Lancaster; S Swift; S Seal; J Mangion; N Collins; S Gregory; C Gumbs; G Micklem
Journal:  Nature       Date:  1995 Dec 21-28       Impact factor: 49.962

4.  BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

Authors:  D Stoppa-Lyonnet; P Laurent-Puig; L Essioux; S Pagès; G Ithier; L Ligot; A Fourquet; R J Salmon; K B Clough; P Pouillart; C Bonaïti-Pellié; G Thomas
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

Authors:  D Shattuck-Eidens; A Oliphant; M McClure; C McBride; J Gupte; T Rubano; D Pruss; S V Tavtigian; D H Teng; N Adey; M Staebell; K Gumpper; R Lundstrom; M Hulick; M Kelly; J Holmen; B Lingenfelter; S Manley; F Fujimura; M Luce; B Ward; L Cannon-Albright; L Steele; K Offit; A Thomas
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

6.  Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage.

Authors:  M A Brow; M C Oldenburg; V Lyamichev; L M Heisler; N Lyamicheva; J G Hall; N J Eagan; D M Olive; L M Smith; L Fors; J E Dahlberg
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

7.  A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

Authors:  Y Miki; J Swensen; D Shattuck-Eidens; P A Futreal; K Harshman; S Tavtigian; Q Liu; C Cochran; L M Bennett; W Ding
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Authors:  S V Tavtigian; J Simard; J Rommens; F Couch; D Shattuck-Eidens; S Neuhausen; S Merajver; S Thorlacius; K Offit; D Stoppa-Lyonnet; C Belanger; R Bell; S Berry; R Bogden; Q Chen; T Davis; M Dumont; C Frye; T Hattier; S Jammulapati; T Janecki; P Jiang; R Kehrer; J F Leblanc; J T Mitchell; J McArthur-Morrison; K Nguyen; Y Peng; C Samson; M Schroeder; S C Snyder; L Steele; M Stringfellow; C Stroup; B Swedlund; J Swense; D Teng; A Thomas; T Tran; M Tranchant; J Weaver-Feldhaus; A K Wong; H Shizuya; J E Eyfjord; L Cannon-Albright; M Tranchant; F Labrie; M H Skolnick; B Weber; A Kamb; D E Goldgar
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

9.  Rapid detection of BRCA1 mutations by the protein truncation test.

Authors:  F B Hogervorst; R S Cornelis; M Bout; M van Vliet; J C Oosterwijk; R Olmer; B Bakker; J G Klijn; H F Vasen; H Meijers-Heijboer
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

10.  Detection of mutations in human genes by a new rapid method: cleavage fragment length polymorphism analysis (CFLPA).

Authors:  S Rossetti; S Englisch; E Bresin; P F Pignatti; A E Turco
Journal:  Mol Cell Probes       Date:  1997-04       Impact factor: 2.365

View more
  1 in total

1.  Vertical transmission of Chlamydia trachomatis in Chongqing China.

Authors:  Jialin Yu; Shixiao Wu; Fang Li; Linyan Hu
Journal:  Curr Microbiol       Date:  2009-01-03       Impact factor: 2.188

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.